Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 679850, 11 pages
http://dx.doi.org/10.1155/2015/679850
Research Article

CD40 Ligand Deficient C57BL/6 Mouse Is a Potential Surrogate Model of Human X-Linked Hyper IgM (X-HIGM) Syndrome for Characterizing Immune Responses against Pathogens

1Department of Molecular Biomedicine, CINVESTAV-IPN, Avenue IPN 2508, Zacatenco, 07360 México, DF, Mexico
2Department of Immunology, Escuela Nacional de Ciencias Biológicas IPN, Prolongación de Carpio y Plan de Ayala, 11340 México, DF, Mexico
3Department of Infectomics and Molecular Pathogenesis, CINVESTAV-IPN, Avenue IPN 2508, Zacatenco, 07360 México, DF, Mexico

Received 17 November 2014; Accepted 10 December 2014

Academic Editor: Monica Fedele

Copyright © 2015 Catalina Lopez-Saucedo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Johnson, A. H. Filipovich, and K. Zhang, “X-linked hyper IgM syndrome,” in SourceGeneReviews, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., pp. 1993–2014, University of Washington, Seattle, Wash, USA, 2007. View at Google Scholar
  2. A. Etzioni and H. D. Ochs, “The hyper IgM syndrome—an evolving story,” Pediatric Research, vol. 56, no. 4, pp. 219–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Schönbeck and P. Libby, “The CD40/CD154 receptor/ligand dyad,” Cellular and Molecular Life Sciences, vol. 58, no. 1, pp. 4–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Gathmann, B. Grimbacher, J. Beauté et al., “The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008,” Clinical & Experimental Immunology, vol. 157, supplement s1, pp. 3–11, 2009. View at Publisher · View at Google Scholar
  5. S. Gupta, M. Madkaikar, S. Singh, and S. Sehgal, “Primary immunodeficiencies in India: a perspective,” Annals of the New York Academy of Sciences, vol. 1250, no. 1, pp. 73–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Cabral-Marques, S. Klaver, L. F. Schimke et al., “First report of Hyper-IgM síndrome registry of the latin american society for immunodeficiencies: novel mutation, unique infections, and outcomes,” Journal of Clinical Immunology, vol. 34, pp. 146–156, 2014. View at Google Scholar
  7. A. Vargas-Hernández, L. Berrón-Ruiz, T. Staines-Boone et al., “Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome,” Clinical Genetics, vol. 83, no. 6, pp. 585–587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Winkelstein, M. C. Marino, H. Ochs et al., “The X-linked hyper- IgM syndrome: clinical and immunologic features of 79 patients,” Medicine, vol. 82, no. 6, pp. 373–384, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Croxen, R. J. Law, R. Scholz, K. M. Keeney, M. Wlodarska, and B. B. Finlay, “Recent advances in understanding enteric pathogenic Escherichia coli,” Clinical Microbiology Reviews, vol. 26, no. 4, pp. 822–880, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. R. Renshaw, W. C. Fanslow III, R. J. Armitage et al., “Humoral immune responses in CD40 ligand-deficient mice,” The Journal of Experimental Medicine, vol. 180, no. 5, pp. 1889–1900, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Xu, T. M. Foy, J. D. Laman et al., “Mice deficient for the CD40 ligand,” Immunity, vol. 1, no. 5, pp. 423–431, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Bernal-Reynaga, R. Thompson-Bonilla, C. Lopez-Saucedo, M. Pech-Armenta, S. Estrada-Parra, and T. Estrada-Garcia, “C57-CD40 ligand deficient mice: a potential model for enterotoxigenic Escherichia coli (H10407) colonization,” Veterinary Immunology and Immunopathology, vol. 152, no. 1-2, pp. 50–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Cosyns, S. Tsirkin, M. Jones, R. Flavell, H. Kikutani, and A. R. Hayward, “Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice,” Infection and Immunity, vol. 66, no. 2, pp. 603–607, 1998. View at Google Scholar · View at Scopus
  14. S. A. Luperchio and D. B. Schauer, “Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia,” Microbes and Infection, vol. 3, no. 4, pp. 333–340, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. S. W. Barthold, G. L. Coleman, R. O. Jacoby, E. M. Livestone, and A. M. Jonas, “Transmissible murine colonic hyperplasia,” Veterinary Pathology, vol. 15, no. 2, pp. 223–236, 1978. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Collins, K. M. Keeney, V. F. Crepin et al., “Citrobacter rodentium: infection, inflammation and the microbiota,” Nature Reviews Microbiology, vol. 12, no. 9, pp. 612–623, 2014. View at Publisher · View at Google Scholar
  17. E. Johnson and S. W. Barthold, “The ultrastructure of transmissible murine colonic hyperplasia,” The American Journal of Pathology, vol. 97, no. 2, pp. 291–313, 1979. View at Google Scholar · View at Scopus
  18. C. P. Simmons, S. Clare, M. Ghaem-Maghami et al., “Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium,” Infection and Immunity, vol. 71, no. 9, pp. 5077–5086, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Bry and M. B. Brenner, “Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen,” The Journal of Immunology, vol. 172, no. 1, pp. 433–441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Belzer, Q. Liu, M. C. Carroll, and L. Bry, “The role of specific IgG and complement in combating aprimary mucosal infection of the gut epithelium,” European Journal of Microbiology and Immunology, vol. 1, no. 4, pp. 311–318, 2011. View at Publisher · View at Google Scholar
  21. C. López-Saucedo, J. F. Cerna, N. Villegas-Sepulveda et al., “Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli,” Emerging Infectious Diseases, vol. 9, no. 1, pp. 127–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. O. L. Wei, A. Hilliard, D. Kalman, and M. Sherman, “Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium,” Infection and Immunity, vol. 73, no. 4, pp. 1978–1985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Mundy, T. T. MacDonald, G. Dougan, G. Frankel, and S. Wiles, “Citrobacter rodentium of mice and man,” Cellular Microbiology, vol. 7, no. 12, pp. 1697–1706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Bry, M. Brigl, and M. B. Brenner, “CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium,” Infection and Immunity, vol. 74, no. 1, pp. 673–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. V. Newman, B. A. Zabel, S. S. Jha, and D. B. Schauer, “Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice,” Infection and Immunity, vol. 67, no. 11, pp. 6019–6025, 1999. View at Google Scholar · View at Scopus
  26. H.-J. Chiu and W.-J. Syu, “Functional analysis of EspB from enterohaemorrhagic Escherichia coli,” Microbiology, vol. 151, no. 10, pp. 3277–3286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Fikrig, S. W. Barthold, M. Chen, I. S. Grewal, J. Craft, and R. A. Flavell, “Protective antibodies in murine Lyme disease arise independently of CD40 ligand,” The Journal of Immunology, vol. 157, no. 1, pp. 1–3, 1996. View at Google Scholar · View at Scopus
  28. S. E. Connolly and J. L. Benach, “The versatile roles of antibodies in Borrelia infections,” Nature Reviews Microbiology, vol. 3, no. 5, pp. 411–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Maaser, M. P. Housley, M. Iimura et al., “Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies,” Infection and Immunity, vol. 72, no. 6, pp. 3315–3324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. I. M. E. Desar, M. van Deuren, T. Sprong et al., “Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia,” Clinical and Experimental Immunology, vol. 156, no. 3, pp. 434–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. R. McLean, K. K. Miller, J. W. Schrader, and A. K. Junker, “Biased immunoglobulin G (IgG) subclass production in a case of hyper-IgM syndrome,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 6, pp. 1192–1193, 2004. View at Publisher · View at Google Scholar · View at Scopus